We asked whether plasma concentrations of endothelin-1 (ET-1) or adrenomedullin (ADM) are altered by different activity states of the renin-angiotensin-aldosterone system (RAAS). Levels of ET-1 and ADM were studied in patients with primary aldosteronism (n = 15), essential hypertension (n = 15), and adrenal insufficiency (n = 7). Effects of fludrocortisone, dexamethasone, or spironolactone treatment on ET-1 and ADM levels were also analyzed. Plasma ET-1 and ADM concentrations did not differ significantly between the patient groups. After fludrocortisone, dexamethasone, or spironolactone treatment, both ET-1 and ADM did not change significantly. The data support the hypothesis that the RAAS is not directly linked with the ET-1/ADM system.

Download full-text PDF

Source
http://dx.doi.org/10.3109/10641963.2012.681729DOI Listing

Publication Analysis

Top Keywords

et-1 adm
16
fludrocortisone dexamethasone
12
dexamethasone spironolactone
12
spironolactone treatment
8
treatment et-1
8
et-1
5
adm
5
endothelin-1 adrenomedullin
4
adrenomedullin plasma
4
plasma levels
4

Similar Publications

Background: Endothelin-1 (ET-1) and adrenomedullin (ADM) are commonly known as vasoactive peptides that regulate vascular homeostasis. Less recognised is the fact that both peptides could affect glucose metabolism. Here, we investigated whether ET-1 and ADM, measured as C-terminal-proET-1 (CT-proET-1) and mid-regional-proADM (MR-proADM), respectively, were associated with incident type 2 diabetes.

View Article and Find Full Text PDF

Purpose: The aim of this study was to analyse the course of adrenomedullin (ADM) and endothelin-1 (ET-1) levels in patients with vasodilatory shock after cardiac surgery and to explore differences compared to patients after uncomplicated coronary artery bypass graft (CABG) surgery. ADM and ET-1 are involved in the vasomotor response during vasodilatory shock.

Materials And Methods: We included 32 patients with vasodilatory shock (study group) and 10 patients after uncomplicated CABG surgery (control group).

View Article and Find Full Text PDF

Differential response to hypoxia in leiomyoma and myometrial cells.

Life Sci

February 2022

Department of Gynecology and Obstetrics, Johns Hopkins University, 4940 Eastern Ave, Baltimore 21224-2780, MD, USA. Electronic address:

Aims: Recent evidence suggests that repetitive hypoxia occurs during menstrual cycles due to vasoconstriction and myometrial contraction. It is unknown if hypoxia contributes to the development of uterine leiomyoma, the most common tumor of the female reproductive system. This study aims to characterize the response to hypoxia in leiomyoma and myometrial cells; and determine if an aberrant leiomyoma response to hypoxia may contribute to leiomyomatogenesis.

View Article and Find Full Text PDF

Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat.

Stem Cell Res Ther

October 2021

Stroke Center and Department of Neurology, Chang Gung Memorial Hospital, Linkou Medical Center, and College of Medicine, Chang Gung University, No. 5, Fu-Hsing Street, Kweishan, Taoyuan, 333, Taiwan.

Article Synopsis
  • The study investigates the combination of induced pluripotent stem cells (iPSCs) and low-dose recombinant tissue plasminogen activator (rt-PA) to enhance thrombolysis for treating acute ischemic stroke while minimizing bleeding risks.
  • In an animal model, low-dose rt-PA alone was ineffective in recanalizing arteries, but when combined with iPSCs, significant recanalization was observed 24 hours to 7 days after treatment.
  • The treatment with iPSCs reduced inflammatory markers and increased the expression of beneficial factors like Angiopoietin-2, Brain-Derived Neurotrophic Factor, and Vascular Endothelial Growth Factor, indicating enhanced healing and recovery processes in injured arteries.
View Article and Find Full Text PDF

Hyperpigmentation is a dermatological condition characterized by the overaccumulation and/or oversecretion of melanin pigment. The efficacy of curcumin as an anti-melanogenic therapeutic has been recognized, but the poor stability and solubility that have limited its use have inspired the synthesis of novel curcumin analogs. We have previously reported on comparisons of the anti-melanogenic activity of four novel chemically modified curcumin (CMC) analogs, CMC2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!